CDAP’s $1B a year headache By KEN ALI The cost of Chronic Disease Assistance Programme (CDAP) drugs is a major headache for taxpayers. That is why the Government is reviewing the “a complex array of deep-seated and interconnected challenges” in the CDAP system.NIPDEC, which handles the State’s medical formulary, is paying close to $1 billion…
This content is for 3 Months, 6 Months, and 12 Months members only.
Join Now
Join Now
Already a member? Log in here
